Products Categories
CAS No.: | 518-28-5 |
---|---|
Name: | (5R,5aR,8aR,9R)-5,8,8a,9-Tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-furo(3',4':6,7)naphtho[2,3-d]-1,3-dioxol-6(5aH)-one |
Article Data: | 43 |
Molecular Structure: | |
Formula: | C22H22O8 |
Molecular Weight: | 414.412 |
Synonyms: | Podophyllinic acid lactone;(5R,5aR,8aR,9R)-5,8,8a,9-Tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-furo(3',4':6,7)naphtho[2,3-d]-1,3-dioxol-6(5aH)-one; |
EINECS: | 208-250-4 |
Density: | 1.37 g/cm3 |
Melting Point: | 183-184 °C(lit.) |
Boiling Point: | 597.92 °C at 760 mmHg |
Flash Point: | 210.181 °C |
Appearance: | off-white fine crystalline powder |
Hazard Symbols: | T |
Risk Codes: | 21-25-36/37/38-23/25-23/24/25 |
Safety: | 36/37/39-45-26 |
Transport Information: | UN 3462 6.1/PG 2 |
PSA: | 92.68000 |
LogP: | 2.40920 |
podofilox
Conditions | Yield |
---|---|
With L-Selectride In tetrahydrofuran at -78℃; for 0.25h; | 93% |
With L-Selectride In tetrahydrofuran at -78℃; for 1.5h; Inert atmosphere; | 87% |
With lithium tri-t-butoxyaluminum hydride In diethyl ether at -78 - 20℃; for 18h; optical yield given as %de; diastereoselective reaction; | 79% |
With L-Selectride In tetrahydrofuran at -78℃; for 2h; Inert atmosphere; | 70% |
(5R,6R,7R,8R)-methyl 8-hydroxy-7-(hydroxymethyl)-5-(3,4,5-trimethoxyphenyl)-5,6,7,8-tetrahydronaphtho[2,3-d][1,3]dioxole-6-carboxylate
podofilox
Conditions | Yield |
---|---|
With 4 A molecular sieve; zinc(II) chloride In tetrahydrofuran at 64℃; for 2.5h; | 85% |
With molecular sieve; zinc(II) chloride In tetrahydrofuran | 75% |
With 4 A molecular sieve; zinc(II) chloride In tetrahydrofuran for 2.5h; Heating; Yield given; |
(1R,2R,3R,4R)-4-O-(2'-trimethylsilylethoxy)methylpodophyllotoxin
podofilox
Conditions | Yield |
---|---|
With ethanethiol; magnesium bromide In diethyl ether; benzene at 0 - 20℃; for 11h; SEM deprotection; | 81% |
(5R,5aR,8aR,9R)-9-((tert-butyldimethylsilyl)oxy)-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one
podofilox
Conditions | Yield |
---|---|
With triethylamine hydrofluoride In acetonitrile for 72h; Ambient temperature; | 79% |
With tetrabutyl ammonium fluoride; acetic acid In tetrahydrofuran at 0℃; for 2h; Inert atmosphere; | 54% |
Conditions | Yield |
---|---|
With titanium tetrachloride; zinc In tetrahydrofuran at -20 - -10℃; for 4h; McMurry reaction; Inert atmosphere; | A 45% B 9% C n/a D n/a |
Conditions | Yield |
---|---|
With titanium tetrachloride; zinc In tetrahydrofuran at -20 - -10℃; for 4h; McMurry reaction; Inert atmosphere; optical yield given as %de; | A 45% B 9% C n/a D n/a |
Conditions | Yield |
---|---|
With trifluoroacetic acid In tetrahydrofuran; water at 0 - 25℃; for 27h; Inert atmosphere; | A 33% B 43% |
With trifluoroacetic acid In tetrahydrofuran; water at 0 - 20℃; for 24h; Overall yield = 76 %; Overall yield = 43 mg; |
Conditions | Yield |
---|---|
With titanium tetrachloride; zinc In tetrahydrofuran at -20 - -10℃; for 4h; McMurry reaction; Inert atmosphere; | A 40% B n/a C n/a |
Conditions | Yield |
---|---|
With titanium tetrachloride; zinc In tetrahydrofuran at -20 - -10℃; for 4h; McMurry reaction; Inert atmosphere; optical yield given as %de; | A 40% B 7% C n/a D n/a |
Conditions | Yield |
---|---|
With titanium tetrachloride; zinc In tetrahydrofuran at -20 - -10℃; for 4h; McMurry reaction; Inert atmosphere; optical yield given as %de; | A 40% B 8% C n/a D n/a |
What can I do for you?
Get Best Price
The Podophyllotoxin, with CAS registry number 518-28-5, belongs to the following product categories: (1)Plant Oils, Toxins, Phenolic Acids & Derivatives; (2)Natural Plant Extract; (3)Microtobule Inhibitors; (4)Cancer Research; (5)Microtubule Inhibitors; (6)Antitumor Agents; (7)Cell Signaling and Neuroscience; (8)Cytoskeleton and Extracellular Matrix. It has the systematic name of (5R,5aR,8aR,9R)-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one. This chemical is a kind of off-white fine crystalline powder. And it should be stored at the temperature of 2-8°C. This chemical is exciting leads for anti-tumor agent. For instance, podophyllotoxin is the pharmacological precursor for the important anticancer drug etoposide. It is also used as a gel or solution to treat genital warts with noticeably shorter duration and fewer side effects.
Physical properties of Podophyllotoxin: (1)ACD/LogP: 2.35; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 2.345; (4)ACD/LogD (pH 7.4): 2.345; (5)ACD/BCF (pH 5.5): 35.633; (6)ACD/BCF (pH 7.4): 35.633; (7)ACD/KOC (pH 5.5): 449.188; (8)ACD/KOC (pH 7.4): 449.188; (9)#H bond acceptors: 8; (10)#H bond donors: 1; (11)#Freely Rotating Bonds: 5; (12)Polar Surface Area: 92.68 Å2; (13)Index of Refraction: 1.606; (14)Molar Refractivity: 104.282 cm3; (15)Molar Volume: 302.394 cm3; (16)Polarizability: 41.341×10-24cm3; (17)Surface Tension: 52.765 dyne/cm; (18)Density: 1.37 g/cm3; (19)Flash Point: 210.181 °C; (20)Enthalpy of Vaporization: 93.645 kJ/mol; (21)Boiling Point: 597.92 °C at 760 mmHg; (22)Vapour Pressure: 0 mmHg at 25°C.
Preparation: this chemical can be prepared by Epipodophyllotoxin. This reaction will need reagents ethanol, sodium acetate.
Uses of Podophyllotoxin: it can be used to produce 4-deoxypicropodophyllin. This reaction will need reagent H2 and solvent acetic acid. The reaction time is 24 hour(s). The yield is about 88%.
When you are using this chemical, please be cautious about it as the following:
The Podophyllotoxin irritates to eyes, respiratory system and skin. This chemical is harmful in contact with skin. And it is toxic by inhalation, in contact with skin and if swallowed. When use it, wear suitable protective clothing, gloves and eye/face protection. If contact with eyes, rinse immediately with plenty of water and seek medical advice. In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
You can still convert the following datas into molecular structure:
(1)SMILES: COc1cc(cc(c1OC)OC)[C@@H]2c3cc4c(cc3[C@@H]([C@@H]5[C@@H]2C(=O)OC5)O)OCO4
(2)InChI: InChI=1/C22H22O8/c1-25-16-4-10(5-17(26-2)21(16)27-3)18-11-6-14-15(30-9-29-14)7-12(11)20(23)13-8-28-22(24)19(13)18/h4-7,13,18-20,23H,8-9H2,1-3H3/t13-,18+,19-,20-/m0/s1
(3)InChIKey: YJGVMLPVUAXIQN-XVVDYKMHBO
(4)Std. InChI: InChI=1S/C22H22O8/c1-25-16-4-10(5-17(26-2)21(16)27-3)18-11-6-14-15(30-9-29-14)7-12(11)20(23)13-8-28-22(24)19(13)18/h4-7,13,18-20,23H,8-9H2,1-3H3/t13-,18+,19-,20-/m0/s1
(5)Std. InChIKey: YJGVMLPVUAXIQN-XVVDYKMHSA-N
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
cat | LD50 | intramuscular | 4mg/kg (4mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA SKIN AND APPENDAGES (SKIN): CUTANEOUS SENSITIZATION (EXPERIMENTAL): AFTER TOPICAL EXPOSURE | Federation Proceedings, Federation of American Societies for Experimental Biology. Vol. 7, Pg. 249, 1948. |
cat | LD50 | intravenous | 1700ug/kg (1.7mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA GASTROINTESTINAL: NAUSEA OR VOMITING | Federation Proceedings, Federation of American Societies for Experimental Biology. Vol. 7, Pg. 249, 1948. |
cat | LDLo | subcutaneous | 300ug/kg (0.3mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD GASTROINTESTINAL: NAUSEA OR VOMITING | Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 28, Pg. 32, 1891. |
chicken | LDLo | subcutaneous | 6250ug/kg (6.25mg/kg) | BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 28, Pg. 32, 1891. |
dog | LDLo | subcutaneous | 1mg/kg (1mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD GASTROINTESTINAL: NAUSEA OR VOMITING | Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 28, Pg. 32, 1891. |
frog | LDLo | parenteral | 152mg/kg (152mg/kg) | BEHAVIORAL: STIFFNESS | Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 28, Pg. 32, 1891. |
mouse | LD50 | intraperitoneal | 30mg/kg (30mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 11, Pg. 327, 1961. | |
mouse | LD50 | intravenous | 56mg/kg (56mg/kg) | U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. Vol. NX#01679, | |
mouse | LD50 | oral | 100mg/kg (100mg/kg) | PCT Vol. #86-04062, | |
mouse | LDLo | subcutaneous | 24600ug/kg (24.6mg/kg) | Toxicon. Vol. 8, Pg. 85, 1970. | |
pigeon | LDLo | subcutaneous | 10mg/kg (10mg/kg) | BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 28, Pg. 32, 1891. |
rabbit | LD50 | intravenous | 5mg/kg (5mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA SKIN AND APPENDAGES (SKIN): CUTANEOUS SENSITIZATION (EXPERIMENTAL): AFTER TOPICAL EXPOSURE | Federation Proceedings, Federation of American Societies for Experimental Biology. Vol. 7, Pg. 249, 1948. |
rabbit | LD50 | skin | 200mg/kg (200mg/kg) | PCT Vol. #86-04062, | |
rat | LD50 | intramuscular | 3mg/kg (3mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA GASTROINTESTINAL: NAUSEA OR VOMITING | Federation Proceedings, Federation of American Societies for Experimental Biology. Vol. 7, Pg. 249, 1948. |
rat | LD50 | intraperitoneal | 15mg/kg (15mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA GASTROINTESTINAL: NAUSEA OR VOMITING | Federation Proceedings, Federation of American Societies for Experimental Biology. Vol. 7, Pg. 249, 1948. |
rat | LD50 | intravenous | 8700ug/kg (8.7mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA GASTROINTESTINAL: NAUSEA OR VOMITING | Federation Proceedings, Federation of American Societies for Experimental Biology. Vol. 7, Pg. 249, 1948. |
rat | LD50 | skin | 500mg/kg (500mg/kg) | PCT Vol. #86-04062, | |
rat | LD50 | subcutaneous | 8mg/kg (8mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Proceedings of the Society for Experimental Biology and Medicine. Vol. 77, Pg. 269, 1951. |